REQUEST A DEMO
Total
USD $0.00
Search more companies

GP Yao Oblfarm (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: GP Yao Oblfarm Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GP Yao Oblfarm is a company based in Russia, with its head office in Yaroslavl. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on May 22, 1997. There was a net sales revenue drop of 16.84% reported in GP Yao Oblfarm’s latest financial highlights for 2022. There was a total growth of 82.74% in GP Yao Oblfarm’s total assets over the same period. The net profit margin of GP Yao Oblfarm increased by 23.95% in 2022.

Headquarters
1-Ya Putevaya, 7
Yaroslavl; Yaroslavl Oblast; Postal Code: 150030

Contact Details: Purchase the GP Yao Oblfarm report to view the information.

Website: http://yaroblfarm.ru

Basic Information
Outstanding Shares:
Purchase the GP Yao Oblfarm report to view the information.
Registered Capital:
Purchase the GP Yao Oblfarm report to view the information.
Incorporation Date:
May 22, 1997
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
As Sfpim (Yafk)
Company Performance
Financial values in the chart are available after GP Yao Oblfarm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-16.84%
Total operating revenue
-16.84%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
16634.01%
Total assets
82.74%
Total equity
677.76%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
23.95%
Return on Equity (ROE)
82.95%
Quick Ratio
0.57%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?